Fundraising Fox

Mitsubishi UFJ Capital

Corporate VC

Tokyo · Pre-Seed–Late Stage · 5 people tracked

Also known as 三菱UFJキャピタル株式会社

Fox Verdict
Sign up to see your fit

Investment thesis

Mitsubishi UFJ Capital (三菱UFJキャピタル) is a Japanese venture capital firm that invests in and supports startups, publishing news on new investments and IPOs of its portfolio companies.

Source: firm website, verified Aug 24, 2026.

Stage
Pre-Seed–Late Stage
Check
$952K – $269M
HQ
Tokyo, JP
Instruments
Equity
Founded
1974
AUM
$500M
Tracked investments
17

Team · 5 people

from the firm's website

What they invest in

from 16 of 17 portfolio companies

AI & Machine Learning ×7Deep Tech ×7Enterprise Software ×4Healthtech ×4SaaS ×4Biotech ×3Developer Tools ×3Medical Devices ×3

HQs:Japan×13

Investments · 17 tracked

founders shown can be your intro path

By year:2025 · 22024 · 12023 · 25 dated

FUNDiT IT領域に特化した共創型M&Aとロールアップを行う事業投資を展開fundit.jp✓ verified

FUNDiT acquires and operates small to mid-sized IT businesses using AI and big data analysis for M&A targeting and operational improvement.

AI & Machine LearningEnterprise SoftwareShinagawa, JP

Co-investorsShizuoka CapitalDual Bridge CapitalJapan Post Insurance NEXT PartnersMitsui Sumitomo Insurance CapitalNANKAI NEXT VenturesUNITED+2 more

Global Vascular株式会社g-vasc.comin✓ verified

Global Vascular develops medical devices based on its BioDiamond Technology, including antithrombotic diamond (F-DLC) coatings, drug-eluting stents, and catheters for vascular and interventional treatments.

Deep TechHealthtechMedical DevicesNew MaterialsTokyo, JP

Kenta Bito(Founder & CEO)inShunto Maegawa(Founder & CTO)Emi Matsuoka(COO)

BoardTerumitsu Hasebe(Director)

Co-investorsFast Track InitiativeTokyo University of Science Innovation CapitalMitsui Sumitomo Insurance CapitalSumitomo Mitsui Trust Bank

HISHOH Biopharma㈱hishoh.jp✓ verified

HISHOH Biopharma develops novel immunotherapy drugs based on allergen immunotherapy (including sublingual immunotherapy) to treat IgE-mediated Type I allergic diseases such as allergic rhinitis, asthma, and atopic dermatitis.

BiotechDeep TechHealthtech

Naoki Sakurai(Representative Director & President)Toru Seo(Director / Chief Business Development Officer)Joji Hayashida(Director / Chief Operating Officer)

Co-investorsDBJ Capital

Imironimiron.io✓ verified

Imiron develops formal verification and mathematical modelling technology for learning-enabled, mission-critical systems, applying formal methods to system design and verification.

AI & Machine LearningData & InfrastructureDeep TechDeveloper ToolsSaaSTokyo, JP

Ichiro Hasuo(Co-founder & Chief Scientific Officer)inMasakazu Adachi(Co-founder & CEO)James Haydon(Co-founder & CTO)in

Co-investorsDG Daiwa VenturesThe Gogin Capital

Link Us.Colink-us.co.jpin✓ verified

LINK-US Co., Ltd. develops, designs, and manufactures devices based on ultrasonic complex vibration and high-power ultrasonic technology, including room-temperature bonding equipment for joining same and dissimilar metal materials.

Advanced ManufacturingDeep TechHardwareTokyo, JP

Jun Mitsuyuki(Representative Director)

Co-investorsMiyako CapitalShizuoka CapitalKepple GroupMizuho CapitalSMBC Venture CapitalSumitomo Mitsui Trust nvestment Co. Ltd.

Mjolnir Swmjolnir-sw.comin𝕏✓ verified

MJOLNIR SPACEWORKS (MSW) develops hybrid rocket engines and weld-free tanks with the goal of mass-producing rockets, using its own engine technology focused on safety, simplicity, and cost.

Deep TechHardwareSpace TechTokyo, JP

Kazuo Yonekura(Chief Executive Officer)Mitsunori Itoh(Chief Research Officer)Yohei Sato(Chief Technology Officer)

Co-investorsJIC Venture Growth InvestmentsUntroD Capital

Rehab For Japanrehabforjapan.comin✓ verified

Rehab for JAPAN develops and provides "Rehab Cloud," a SaaS platform for elderly care and rehabilitation providers, along with "Rehab Studio," an online rehabilitation service, and conducts R&D on AI-based care technology.

AI & Machine LearningData & InfrastructureDigital HealthHealthtechLongevitySaaSTokyo, JP

大久保亮(代表取締役社長 CEO)in

Co-investorsCapital Medica VenturesEISAI CO.,LTDMonex VenturesMTG VenturesNissay CapitalOmron Ventures+5 more

ROUTE06route06.co.jpin𝕏✓ verified

ROUTE06 builds AI-driven development platforms (Acsim, Giselle, Liam) and provides consulting, enterprise system development, and DX support services for large companies.

AI & Machine LearningDeveloper ToolsEnterprise SoftwareTokyo, JP

遠藤 崇史(代表取締役 (CEO/Founder))松本 均(取締役 (Co-founder))重岡 正(取締役CTO (Co-founder))Tadashi Shigeoka(Founder)in見浪 康平(執行役員CFO)Takafumi Endoin

Co-investorsDelight VenturesALL STAR SAAS FUNDGenesia VenturesJAFCO GroupMizuho CapitalSMBC Venture Capital

エクセルギー・パワー・システムズexergyworld.com✓ verified

Exergy Power Systems develops and operates hybrid battery energy storage systems (BESS) and energy management systems for large-scale power consumers, factories, hospitals, and grid operators seeking to achieve net-zero targets.

CleantechClimate TechEnergyTokyo, JP

Dr Miura Daisuke(CEO)

Co-investorsNissay CapitalSMBC Venture CapitalGlobal Brain

セルスペクト株式会社cellspect.com✓ verified

Cellspect develops next-generation clinical diagnostic reagents and in-vitro diagnostic products based on deep-tech, covering diagnostic technologies from biomarker discovery to treatment monitoring.

BiotechDeep TechDigital HealthHealthtechMedical DevicesMorioka, JP

Takuya Iwabuchi(代表取締役兼CEO (Representative Director & CEO))Wataru Hojo(Executive Officer & CTO)

Co-investorsTokyo University of Science Innovation CapitalIwagin Business Creation Capital

株式会社トライバルメディアハウスtribalmedia.co.jp𝕏✓ verified

Tribal Media House is a digital marketing company that develops marketing logic and knowledge, having published over 20 books on the subject.

AdTechMarketing TechMedia & EntertainmentTokyo, JP

Noriyuki Ikeda(代表取締役社長 (President & CEO))

Co-investorsi-nest capitalMizuho Capital

株式会社マツリカmazrica.com𝕏✓ verified

A team/recruitment page for Mazrica, listing company members and links to hiring materials.

AI & Machine LearningSaaSSales TechTokyo, JP

黒佐英司(代表取締役CEO)Eiji Kurosain

Co-investorsDnx VenturesIyogin CapitalNTT DOCOMO VenturesOita Venture CapitalArchetype VenturesKiraboshi Capital+5 more

Azulazul.comin𝕏Feb 2024 · $3.2M

Azul provides enterprise Java runtime solutions, including a supported OpenJDK distribution with long-term support, and offers migration and advisory services for moving off the Oracle JDK.

Cloud ComputingDeveloper ToolsEnterprise Software

Co-investorsPartners for GrowthPartners for Growth (PFG)GS FuturesLead Edge CapitalSpiral CapitalSpurcle+3 more

CADDicaddi.jpJul 2023 · $89M

Manufacturing technology company; MGP invested in its Series C extension round (2025).

Yushiro Kato(Founder)in

Co-investorsMinerva Growth PartnersAtomicoDCM VenturesGlobal BrainGlobis Capital PartnersSMBC Venture Capital+1 more

Citadel AIcitadel.co.jpin𝕏Jul 2023

Citadel AI is a platform for evaluating and monitoring various AI systems including large language models, image AI, and tabular AI.

AI & Machine LearningEnterprise SoftwareTokyo, JP

Kenny Song(Founder)in

Co-investorsTechstarsUTokyo Innovation Platform Co. Ltd.ANRICoral CapitalSuntory Holdings Limited

Manabiemanabie.cominApr 2025 · $23M

Manabie builds end-to-end digital infrastructure for educational institutions, offering a composable microservices system that covers tutoring, learning management, and operational administration.

AI & Machine LearningEdTechSaaS

Takuya Homma(Founder)inChristy Wong(Founder)in

Co-investorsGlobis Capital PartnersAozora Corporate InvestmentGenesia VenturesJIC Venture Growth Investments

RegCellregcellbio.cominMar 2025 · $45.8M

RegCell Biosciences is a biotechnology company developing regenerative cell therapies, leveraging expertise in cell and gene therapy, manufacturing, and immunology to advance therapeutic treatments.

BiotechDeep TechMedical Devices

Michael McCullar, PhD(Chief Executive Officer)James Ahlers(Chief Financial Officer)Marty Giedlin, PhD(Chief Technology Officer)Tony Hurley(Chief Technical Operations Officer)Steve Kanner, PhD(Chief Scientific Officer)

Co-investorsFast Track InitiativeGlobal BrainKyoto University Innovation CapitalUTEC

Portfolio news

latest coverage across their companies

Frequently asked questions

What stage does Mitsubishi UFJ Capital invest at?
Mitsubishi UFJ Capital invests at the Pre-Seed, Seed, Series A, Series B, Series C, Growth, Late Stage stages.
What is Mitsubishi UFJ Capital's typical check size?
Mitsubishi UFJ Capital typically writes checks of $952K – $269M.
What sectors does Mitsubishi UFJ Capital focus on?
Mitsubishi UFJ Capital focuses on Biotech, Crypto & Web3, Healthtech, SaaS, Sector Agnostic.
Where is Mitsubishi UFJ Capital located?
Mitsubishi UFJ Capital is headquartered in Tokyo, JP.

Images

Mitsubishi UFJ Capital photo

Similar investors

Featured in lists